Nursing Elites

1. Which of the following is a type of heart valve disease where the aortic valve becomes narrowed, restricting blood flow from the heart to the rest of the body?

• A. Aortic stenosis
• B. Mitral stenosis
• C. Tricuspid regurgitation
• D. Pulmonary hypertension

Correct answer: A

Rationale: The correct answer is Aortic stenosis. In aortic stenosis, the aortic valve becomes narrowed, which obstructs the blood flow from the heart to the rest of the body. This condition can lead to symptoms like chest pain, shortness of breath, and fainting. Mitral stenosis (choice B) involves narrowing of the mitral valve, not the aortic valve. Tricuspid regurgitation (choice C) is a condition where the tricuspid valve leaks, causing blood to flow backward in the heart. Pulmonary hypertension (choice D) is high blood pressure in the arteries of the lungs.

2. What is the condition where the arteries in the brain become blocked or narrowed, leading to reduced blood flow and a potential stroke?

• A. Cerebral atherosclerosis
• B. Coronary artery disease
• C. Pulmonary embolism
• D. Peripheral artery disease

Correct answer: A

Rationale: Cerebral atherosclerosis is the correct answer. It is a condition where the arteries in the brain become blocked or narrowed due to plaque buildup, leading to reduced blood flow and an increased risk of stroke. Choice B, Coronary artery disease, specifically affects the arteries supplying blood to the heart, not the brain. Choice C, Pulmonary embolism, involves a blockage in the pulmonary artery that affects blood flow to the lungs, not the brain. Choice D, Peripheral artery disease, refers to a condition where blockages occur in arteries outside of the heart and brain, typically affecting the limbs.

3. What is a type of medication that helps to prevent blood clots by thinning the blood?

• A. Anticoagulant
• B. Beta-blocker
• C. ACE inhibitor
• D. Calcium channel blocker

Correct answer: A

Rationale: Anticoagulants are medications specifically designed to prevent blood clots by thinning the blood. They work by interfering with the body's blood clotting process. Beta-blockers, ACE inhibitors, and calcium channel blockers are medications used for different purposes such as managing blood pressure, heart conditions, and regulating heart rhythm, respectively. However, they do not have the primary function of preventing blood clots like anticoagulants.

4. What is the condition where the blood vessels that supply blood to the legs and feet become narrowed or blocked, causing pain and difficulty walking?

• A. Peripheral artery disease
• B. Raynaud's disease
• C. Varicose veins
• D. Pulmonary embolism

Correct answer: A

Rationale: The correct answer is A, Peripheral artery disease (PAD). PAD is a condition where the blood vessels that supply blood to the legs and feet become narrowed or blocked, leading to decreased blood flow, pain, and difficulty walking, especially during physical activity. Raynaud's disease (choice B) is characterized by vasospasms in the fingers and toes, causing them to turn white or blue. Varicose veins (choice C) are enlarged, twisted veins usually found in the legs. Pulmonary embolism (choice D) is a blockage in one of the pulmonary arteries in the lungs, often caused by a blood clot.

5. A client on spironolactone (Aldactone) has a potassium level of 6.0 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer a potassium supplement.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: The correct action for a client on spironolactone with a potassium level of 6.0 mEq/L is to hold the medication and notify the healthcare provider. Spironolactone is a potassium-sparing diuretic that can further elevate potassium levels, which are already high. Administering a potassium supplement (Choice B) would exacerbate the hyperkalemia. Continuing the spironolactone as ordered (Choice C) could lead to worsening hyperkalemia. Increasing the dose of spironolactone (Choice D) would be contraindicated in the presence of elevated potassium levels.

Similar Questions